CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to OCGN

OCU400 Low Dose

Phase 2
Ocugen, Inc. (OCGN)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
OCGNPhase 2

OCU400 Low Dose Phase 2 Est. Readout

OCU400 Low Dose
Mar 2027~STALE
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Retinitis Pigmentosa

Clinical Trial

NCT05203939

Last updated: 1/11/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.